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DL-2-Amino-5-phosphonovaleric acid stimulated calcium influx into synaptosomes i olated from rat brain. 
The increase in Ca2 + permeability of the synaptosomal membranes induced by this amino acid is not mark- 
edly dependent on the membrane potential or Na+ concentration. It is postulated that 2-amino-5-phospho- 
novaleric acid is an agonist for a receptor(s) which regulates intraneuronal free calcium concentrations by 
modulating a selective calcium channel. The observed stimulation of calcium uptake may provide an assay 
system for purification of the endogenous ligand for this receptor and for characterization of its physiologi- 
cal role in neuronal function. 
Ca2 + uptake; DL-2-Amino-5-phosphonovalerate; Synaptosome; Receptor 
1. INTRODUCTION 
Neurons have very active transport systems for 
maintaining their intracellular ionic composition 
and can undergo very large and rapid changes in 
the ionic permeability of their plasma membranes. 
The existence of special mechanisms for calcium 
permeability in excitable cells has been appreciated 
for almost 30 years [l-3]. At least two different 
mechanisms appear to be responsible for active ex- 
trusion of Ca2+ across the neuronal membranes: 
the ATP-driven calcium transporter and the 
Na+/Ca2+ exchanger (review [4]). Return of Ca2+ 
into the interior of neurons is largely by diffusion 
through Ca2+-selective ion channels [1,2,5-81. 
At least four different types of calcium channels 
have been proposed or observed, of which the 
most important appear to be voltage-sensitive 
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channels and receptor-modulated channels (see 
above reviews). Although voltage-dependent 
calcium channels in neuronal membranes are well 
described, calcium movements through receptor- 
mediated channels are much less well character- 
ized. Much remains to be done before an under- 
standing of their properties is achieved [9]. 
Receptor-operated calcium channels have been 
proposed to account for the fact that many 
neurotransmitter ligands activated Ca2+ influx in 
the absence of changes in membrane potential 
[IO-131. 
We have previously observed that the potent 
neurotoxin kainate [14] stimulated uptake of 
calcium by synaptosomes isolated from rat brain. 
Here, we provide evidence that the potent and 
relatively specific antagonist of the NMDA recep- 
tors [ 1% 181 DL-2-amino-5-phosphonovalerate 
(APVA), at millimolar concentrations, also 
stimulates Ca2+ influx into synaptosomes from rat 
brain. This increase in Ca*+ permeability of synap- 
tosomal membranes appears to occur via receptor- 
modulated calcium channels which are different 
from voltage-dependent Ca2+ channels. 
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2. MATERIALS AND METHODS 2.2. Measurements of membrane potential 
Male Sprague-Dawley rats (180-220 g) were 
used throughout the experiments. Crude synap- 
tosomal preparations (Pz fraction) were prepared 
from homogenates of brain cortex by centrifuga- 
tion for 10 min at 20000 x g of the initial low- 
speed supernatant (3 min at 1000 x g). The 
purified synaptosomal fraction was isolated ac- 
cording to Booth and Clark [19]. The final synap- 
tosomal pellets were suspended at approx. 1 mg 
protein/ml in modified Krebs-Henseleit saline 
(140 mM NaCI, 3 mM KCl, 5 mM NaHCOJ, 
1.3 mM MgS04, 1 mM Tris-phosphate, 10 mM 
Tris-Hepes, pH 7.4, containing 10 mM glucose 
and 0.1 mM CaC12). In experiments involving low 
sodium levels (< 1 mM), the Na+ salts were re- 
placed by equal concentrations of choline salts. 
The transmembrane electrical potential was 
estimated from the equilibrium distribution of 
[‘4C]triphenylmethylphosphonium (TPMP; final 
total concentration 1OpM < 0.44 &i/ml) plus 
1 PM tetraphenylboron. The synaptosomes were 
incubated with TPMP and tetraphenylboron, with 
and without amino acid, for 20 min at 30°C. Ali- 
quots (300 ~1) were withdrawn and the synap- 
tosomes centrifuged through a layer of silicone oil. 
The radioactivity was then measured in both the 
pellet and supernatant fractions. The membrane 
potentials were calculated using the Nernst 
equation. 
2.3. Measurements of oxygen consumption 
2.1. Measurements of calcium uptake 
For measurements of 45Ca2+ uptake, 400~~1 ali- 
quots of the resuspended PZ synaptosomal fraction 
were incubated for 10 min at 30°C. Uptake of 
45ca2+ was then initiated by rapid addition of 
400 ~1 Krebs-Henseleit medium containing 45Ca2+ 
(1.25 mM final concentration, 1 &i/ml). At ap- 
propriate times (1, 2, 3, 5, 10, 20 s), uptake of 
4’Ca2+ was terminated by addition of 5 ml ice-cold 
EGTA ‘stopping solution’ containing 140 mM 
NaCl, 3 mM KCl, 5 mM NaHC03, 1 mM Tris- 
phosphate, 3 mM EGTA and 10 mM Tris-Hepes, 
pH 7.4. 
Synaptosomes were incubated for 5 min at 25°C 
in a shaking water bath, transferred to a ther- 
mostatted (25°C) chamber containing a Clark-type 
oxygen electrode and, after a steady rate of oxygen 
consumption was established, the amino acid was 
added. 
2.4. Protein determination 
Protein concentrations were determined by the 
method of Lowry et al. [20] with bovine serum 
albumin as the standard. 
2.5. Statistical analysis 
Each sample was immediately filtered through a 
prewashed glass-fiber filter using a Millipore 
vacuum filtration apparatus. The filters were 
rapidly washed twice with 5-ml aliquots of the cold 
incubation medium, dried in air, and the radioac- 
tivity measured in a Searle Delta 300 liquid scin- 
tillation counter using an Amersham aqueous 
scintillant (ACS II). To measure the effect of 
amino acid on the uptake of 45Ca2+, the assay solu- 
tion contained APVA at final concentrations from 
0.5 to 10 mM (see table and figure legends for 
details): the amino acid was neutralized to pH 7.4 
by NaOH or Tris base. In experiments testing the 
efficacy of the voltage-dependent channel 
blockers, the assay media also contained cobalt 
chloride (3 mM), lanthanum chloride (6 PM), 
quinacrine (100 PM), verapamil (50pM) or 
ruthenium red (5 or 50pM). 
All values are presented as means + SE. 
Statistical significance was determined using the 
paired t-test applied to the raw data. 
Measurements in the presence of amino acid were 
compared to those in the absence of amino acid 
(control) in the same experiment. The term ‘in- 
dependent experiments’ refers to experiments car- 
ried out on different days and using different 
solutions of amino acid. 
3. RESULTS 
3.1. Effect of APVA on 45Cd+ uptake by 
synaptosomes 
The dependence of the measured 45Ca2+ uptake 
on concentration of APVA is shown in fig.1. The 
45ca2+ uptake increased with increasing APVA 
concentration, becoming statistically significant at 
0.5 mM (P < 0.05). Half-maximal effect occurred 
at approx. 1 mM amino acid. The 45Ca2+ uptake 
induced by addition of 10 mM APVA was 80% 
190 
Volume 218, number 2 FEBS LETTERS 
, 
June 1987 
above control values. This effect was specific for 
APVA since addition of 10 mM concentrations of 
D-glutamate, L-glutamate, D-aspartate, L- 
aspartate, or L-cysteate instead of APVA had no 
effect on 4sCa2+ uptake by the synaptosomes. 
Similarly, no inhibition of the APVA-induced 
45Ca2+ uptake was observed when these com- 
pounds were added either before or at the same 
time as the APVA (not shown). 
- 0.6 
H 
3.2. Time dependence of the effect of APVA on 
45Cd+ uptake by synaptosomes 
Uptake of 4sCa2+ by the synaptosomal fraction 
was measured in the presence and absence of 
5 mM APVA (fig.ZA). The presence of APVA 
resulted in an increase in the uptake of 45Ca2+, 
which became statistically significant (P < 0.05) by 
2 s and was significant at all of the longer times. 
Fig.2B illustrates the difference between the up- 
take of 45Ca2+ in the presence and absence of 
APVA. As shown in this figure, the uptake of 
45Ca2+ induced by APVA occurred with a half- 
time of approx. 3 s. 
0 I 2 5 IO 
[ APVA ] (mM) 
Fig.1. 4sCaz+ uptake in 5 s as a function of APVA 
concentration. Synaptosomes were incubated for 10 min 
at 30°C in Krebs-Henseleit medium containing 3 mM K+ 
and 0.1 mM Ca’+. Aliquots (400 ~1) were added to equal 
volumes of incubation medium containing 45Ca2+ (final 
concentration 1.25 mM) to initiate 45Ca2+ uptake. 
Uptake was terminated after 5 s by injection of 5 ml ice- 
cold stopping solution and rapid filtration. The values 
are the means f SE for 4 experiments. 
3.3. Distribution of API/A-induced Cd’ 
permeability changes in different anatomical 
regions of the brain 
The effect of the amino acid on the uptake of 
decreased the effect of APVA addition by about 
40%. 
3.5. Effect of Na+ concentration on the increase 
4’ca2+ was measured using crude synaptosomal 
fractions prepared from five different anatomical 
regions of the brain: cortex, striatum, hippocam- 
pus, midbrain and cerebellum (table 1). APVA 
stimulated the uptake of 45Ca most strongly in 
synaptosomes from the cortex, while smaller, but 
still statistically significant, stimulations were 
observed in synaptosomes from the striatum, hip- 
pocampus and cerebellum. Only in synaptosomes 
from midbrain was there no significant APVA- 
induced increase in calcium uptake. 
in 45Cd’ uptake induced by APVA 
3.4. The effect of calcium channel blockers and 
ruthenium red on the increased 45Cti+ @take 
induced by APVA 
The importance of Na+ to the APVA-induced 
45Ca2+ uptake in synaptosomes was determined by 
comparing the uptake measured in media which 
contained normal Na+ concentrations (140 mM) to 
that measured in media with very low Na+ concen- 
trations (< 1 mM). As shown in table 3, the amino 
acid stimulated uptake of 45Ca2+ nearly as much 
when the synaptosomes were suspended in media 
with low Na+ concentrations as when they were 
suspended in media with normal Na+ concentra- 
tions. The difference was not statistically signifi- 
cant indicating little or no dependence on Na+ 
concentration. 
The increase in 45Ca2+ uptake induced by APVA 3.6. Effect of the APVA on the synaptosomal 
was measured in the presence and absence of membrane potential and respiratory rate 
3 mM CoC12, 6 PM LaC13, 50pM verapamil, The effect of addition of amino acid on the 
1OOpM quinacrine, 1OOpM nifedipine or 50 pM transmembrane electrical potential of synap- 
ruthenium red (table 2). None of these agents, ex- tosomes was estimated from its effect on the 
cept LaClJ, significantly inhibited the increase in equilibrium distribution of [14C]TPMP. After 
45ca2+ uptake induced by APVA. Lanthanum 20 min incubation with 0 (control) and 5 mM 
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Fig.2. (A,B) Effect of APVA on uptake of 4sCa2+ into 
synaptosomes. The uptake of 45Ca2+ was initiated by 
media containing either 0 mM (control) or 10 mM 
APVA as described in the legend to fig. 1. Each point in 
panel A is the mean + SE for 4 experiments except for 
the 1 s point which was for 3 experiments. The uptake 
in the presence of APVA was greater than that in the 
control sample at each time point longer than 1 s (P < 
0.05, paired t-test applied to the raw data). The points 
in panel B are the calcium uptake in the presence of 
amino acid minus that in its absence. 
Table 1 
Effect of DL-2-amino-S-phosphonovalerate on uptake 
of 4sCa2+ by synaptosomes from different regions of the 
brain 
Region of 
brain 
Uptake of 
calcium 
(% control) 
P value 
Cortex 161 + 8 <o.OOs 
Striatum 140 III 5 <O.Ol 
Hippocampus 137 f 6 <0.05 
Midbrain 114 f 11 n.s. 
Cerebellum 128 f 6 < 0.05 
The uptake of 45Ca ‘+ in 5 s was measured as described 
in section 2. The concentration of APVA was 5 mM. 
The results are expressed as percent of the uptake in the 
absence of amino acid (mean + SE for 4 experiments) 
Table 2 
Effect of APVA on 45Ca2+ uptake by synaptosomes in 
the presence of calcium channel blockers 
Additions Uptake of 4sCa2+ (nmol/mg 
protein per 5 s) 
Control APVA Uptake 
None 0.29 + 0.05 0.53 f 0.07 0.24 
Quinacrine 
(1OOpM) 0.24 + 0.07 0.51 + 0.06 0.27 
CoC12 (3 mM) 0.20 + 0.04 0.49 z!I 0.05 0.29 
LaCls (6 pM) 0.15 f 0.04 0.26 + 0.05 0.11 
Verapamil 
(50 PM) 0.26 f 0.03 0.50 * 0.03 0.24 
Nifedipine 
(100 PM) 0.28 rt 0.045 0.49 + 0.04 0.21 
Ruthenium red 
(50 BM) 0.23 f 0.02 0.46 f 0.05 0.23 
The uptake of 45Ca2+ was initiated by diluting the 
synaptosomal fraction (P2) with an equal volume of 
Krebs-Henseleit medium (3 mM K+) containing 45Ca2+ 
and the indicated amount of channel blocker in the 
absence (control) or presence (APVA) of 10 mM APVA. 
45ca2+ uptake was measured for the first 5 s after 
dilution and the results are presented as means + SE for 
4 experiments 
APVA, the calculated membrane potentials (un- 
corrected for binding of TPMP) were 83.6 +_ 
1.6 mV in control and 78.4 + 3.5 mV in the 
presence of the amino acid (means f SE for three 
experiments). This difference was not statisticaily 
significant. 
Table 3 
The effect of Nat concentration on the uptake of 45Ca2+ 
induced by APVA 
nmol/mg protein per 5 s 
140 mM Na+ 0 mM Na+ 
Control 0.34 f 0.01 0.31 f 0.02 
APVA 0.68 -t 0.03 0.54 -t 0.07 
The uptake of 45Ca2+ was measured in regular Krebs- 
Henseleit medium (140 mM Na+) in a medium in which 
choline was substituted for Na+ (0 mM Na+) as 
described in section 2. All values are expressed as 
means f SE for 4 independent experiments. APVA was 
added to a final concentration of 10 mM 
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The respiratory rates of synaptosomes were 
measured between 1 and 3 min after addition of 
APVA. The amino acid increased the respiratory 
rate by about 25% (P < 0.01). The control 
respiratory rate was 1.79 f 0.2 nmol Oz/min per 
mg protein (means + SE for 3 experiments). 
4. DISCUSSION 
The pharmacological classification of excitatory 
amino acid receptors indicates that several types of 
receptors exist in the vertebrate central nervous 
system. One of them is preferentially activated by 
N-methyl-D-aspartate and this effect is blocked by 
APVA [ 15-181. Current data indicate, however, 
that the effects of APVA cannot be fully explained 
by its ability to block some N-methyl-D-aspartate 
receptors [21-231. Electrophysiological ex- 
periments suggest hat 1OOpM concentrations are 
sufficient to block the N-methyl-D-aspartate 
receptors but at higher concentrations (lOO- 
500 PM, the maximum tested) other effects occur- 
red which could be explained by the presence of 
receptors activated by APVA [21,22]. Our results 
([23]; present paper) are consistent with the 
presence of APVA-activated receptors which in- 
crease the permeability of synaptosomal mem- 
brane to calcium with half-maximal effects at 
approx. 1 mM. 
4.1. Is Na’/&+ exchange responsible for 
APVA-induced 45C~’ uptake? 
The results presented in table 3 show that lower- 
ing the concentration of Na+ in the incubation 
medium to less than 1 mM had no significant ef- 
fect on the increase of uptake of Ca2+ induced by 
this amino acid. This indicates that the observed 
effect is independent of Na+ concentration and 
therefore apparently does not involve Na+/Ca2+ 
exchange. 
4.2. Does APVA activate voltage-dependent 
calcium channels? 
The voltage-dependent calcium channels in 
neuronal membranes can be blocked by many 
metal ions, including Mn’+, Ni’+, Co’+, Cd’+, 
La3+ and at least partially by several organic 
Ca’+-channel blockers, including verapamil and 
nifedipine (see, for example [2,6-8,241). In addi- 
tion, quinacrine [25] and ruthenium red [26-281 
have been reported to block selectively voltage- 
dependent calcium channels. Previous experiments 
showed that CoC12, verapamil and quinacrine, at 
the concentrations used in, these experiments, in- 
hibited the depolarization-dependent 45Ca2+ up- 
take of synaptosomes by more than 80% [14]). 
This is in marked contrast to the fact that these 
agents show little or no effect on the stimulation of 
calcium uptake by APVA. Although La3+ in- 
hibited the increased 45Ca2+ uptake, lanthanum 
ions are known to bind tightly to biological mem- 
branes and to have nonspecific effects on many 
membrane-associated functions. Thus, from these 
data it does not appear that the voltage-dependent 
calcium channels are responsible for the APVA- 
induced calcium movement. 
Ruthenium red has also been reported to be an 
inhibitor of voltage-dependent calcium channels 
[26-281 but is generally used to inhibit both 
passive and active calcium uptake into isolated 
mitochondria [29-311. The lack of effect of 
ruthenium red on the increase in Ca2+ permeability 
of the synaptosomal membrane in the presence of 
APVA not only supports the view that voltage- 
dependent calcium channels were not involved, but 
also provides evidence that uptake of calcium by 
free mitochondria does not contribute significantly 
to the measured uptake of 4sCa2+. 
4.3. APVA appears to act as an agonist. for a 
receptor which modulates calcium-selective 
channels 
The increase in Ca2+ permeability of the plasma 
membrane of synaptosomes by APVA is consistent 
with its activating receptor-modulated calcium 
channels: (i) The effect is saturated by increasing 
amino acid concentrations. (ii) There is a very high 
specificity for the structure of the amino acid; 
close structural analogues have no comparable ef- 
fect nor do they inhibit the effect of APVA. (iii) 
There is biological specificity, i.e. the amount of 
stimulation of calcium uptake is much greater in 
synaptosomes from some anatomical regions of 
the brain than from other anatomical regions. (iv) 
The uptake of calcium through receptor- 
modulated calcium channels is generally not as 
sensitive to the blocking agents used as are the 
voltage-dependent channels. On the other hand, 
APVA is not a natural constituent of the central 
nervous system. We suggest hat it is acting as a 
193 
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nonphysiological agonist for a receptor involved in 
regulation of the metabolism of specific neurons 
by modulating the calcium levels in the neurons. It 
is interesting to note that calcium uptake can be 
used as an assay method for the characterization 
and purification of the endogenous ligand(s) for 
this receptor. 
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